Description

Hear an overview of HDA’s and industry’s policy and advocacy efforts to implement the DSCSA. The session will feature HDA advocates and an FDA veteran who will speak about lessons learned over more than a decade. Further, panelists will share perspectives on FDA’s adoption of a phased approach to the law’s final electronic, interoperable requirements. This session will end with a look ahead to what industry can expect from HDA and FDA in 2025 and beyond.

Description

Industry experts will discuss how the multiphase DSCSA exemptions FDA granted to eligible trading partners will affect operations across the supply chain.

Description

It is essential for manufacturers and wholesalers to work collaboratively to resolve outstanding data issues for a smooth transition of transaction data and product to downstream trading partners. A panel of manufacturer and distributor experts will provide their recommendations for closing data quality gaps with the DSCSA compliance deadlines on the horizon.